相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Index of Ideality of Correlation: new possibilities to validate QSAR: a case study
Andrey A. Toropov et al.
STRUCTURAL CHEMISTRY (2018)
The index of ideality of correlation: A criterion of predictability of QSAR models for skin permeability?
Alla P. Toropova et al.
SCIENCE OF THE TOTAL ENVIRONMENT (2017)
Prediction of gas chromatographic retention indices based on Monte Carlo method
Aleksandar M. Veselinovic et al.
TALANTA (2017)
Be aware of error measures. Further studies on validation of predictive QSAR models
Kunal Roy et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2016)
Monte Carlo-based QSAR modeling of dimeric pyridinium compounds and drug design of new potent acetylcholine esterase inhibitors for potential therapy of myasthenia gravis
Dusan Sokolovic et al.
STRUCTURAL CHEMISTRY (2016)
Chemistry and Pharmacology of Angiotensin-Converting Enzyme Inhibitors
Milosz Regulski et al.
CURRENT PHARMACEUTICAL DESIGN (2015)
Application of SMILES Notation Based Optimal Descriptors in Drug Discovery and Design
Aleksandar M. Veselinovic et al.
CURRENT TOPICS IN MEDICINAL CHEMISTRY (2015)
Insights into the molecular basis of action of the AT1 antagonist losartan using a combined NMR spectroscopy and computational approach
Maria Zervou et al.
BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES (2014)
QSAR Modeling: Where Have You Been? Where Are You Going To?
Artem Cherkasov et al.
JOURNAL OF MEDICINAL CHEMISTRY (2014)
Comparative QSAR and pharmacophore analysis for a series of 2,4-dihydro-3H-1,2,4-triazol-3-ones derivatives as angiotensin II AT1 receptor antagonists
Mukesh C. Sharma et al.
MEDICINAL CHEMISTRY RESEARCH (2014)
Identifying Structural Features Related to the Biological Activity of a Series of AT1 Antagonists from Fragment-based Drug Design
Danielle da C. Silva et al.
PROTEIN AND PEPTIDE LETTERS (2014)
An Integrated Drug Development Approach Applying Topological Descriptors
Alan Talevi et al.
CURRENT COMPUTER-AIDED DRUG DESIGN (2012)
Comparative Studies on Some Metrics for External Validation of QSPR Models
Kunal Roy et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2012)
Quantitative structure-activity relationship of 2-alkyl-4-(biphenylylmethoxy) pyridine derivatives with AT1 receptor antagonistic activity
Jiang Yu-ren et al.
JOURNAL OF CENTRAL SOUTH UNIVERSITY OF TECHNOLOGY (2012)
QSAR Study for Carcinogenicity in a Large Set of Organic Compounds
Pablo R. Duchowicz et al.
CURRENT DRUG SAFETY (2012)
Comparative QSARs for antimalarial endochins: Importance of descriptor-thinning and noise reduction prior to feature selection
Probir Kumar Ojha et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2011)
Further exploring rm2 metrics for validation of QSPR models
Probir Kumar Ojha et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2011)
CORAL: Building up the model for bioconcentration factor and defining it's applicability domain
A. A. Toropov et al.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY (2011)
Best Practices for QSAR Model Development, Validation, and Exploitation
Alexander Tropsha
MOLECULAR INFORMATICS (2010)
Quantitative structure activity relationship analysis of angiotensin II AT1 receptor antagonists
Sarvesh Kumar Paliwal et al.
MEDICINAL CHEMISTRY RESEARCH (2010)
How to Recognize and Workaround Pitfalls in QSAR Studies: A Critical Review
T. Scior et al.
CURRENT MEDICINAL CHEMISTRY (2009)
Are Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers Especially Useful for Cardiovascular Protection?
Hean Teik Ong
JOURNAL OF THE AMERICAN BOARD OF FAMILY MEDICINE (2009)
Exploring the impact of size of training sets for the development of predictive QSAR models
Partha Pratim Roy et al.
CHEMOMETRICS AND INTELLIGENT LABORATORY SYSTEMS (2008)
On some aspects of validation of predictive quantitative structure-activity relationship models
Kunal Roy
EXPERT OPINION ON DRUG DISCOVERY (2007)
Principles of QSAR models validation: internal and external
Paola Gramatica
QSAR & COMBINATORIAL SCIENCE (2007)
Predictive QSAR Modeling workflow, model applicability domains, and virtual screening
Alexander Tropsha et al.
CURRENT PHARMACEUTICAL DESIGN (2007)
Angiotensin II cell signaling: physiological and pathological effects in the cardiovascular system
Puja K. Mehta et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2007)
QSAR modeling of AT1 receptor antagonists using ANN
Qing Su et al.
JOURNAL OF MOLECULAR MODELING (2006)
Proposal of a new binding orientation for non-peptide AT1 antagonists: Homology modeling, docking and three-dimensional quantitative structure-activity relationship analysis
Tiziano Tuccinardi et al.
JOURNAL OF MEDICINAL CHEMISTRY (2006)
The AT2 receptor - A matter of love and hate
UM Steckelings et al.
PEPTIDES (2005)
A 3D-QSAR of angiotensin II (AT1) receptor antagonists based on receptor surface analysis
PA Datar et al.
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2004)
ACE revisited: A new target for structure-based drug design
KR Acharya et al.
NATURE REVIEWS DRUG DISCOVERY (2003)
QSPR modeling of alkanes properties based on graph of atomic orbitals
AA Toropov et al.
JOURNAL OF MOLECULAR STRUCTURE-THEOCHEM (2003)
Angiotensin II AT1 receptor antagonists. Clinical implications of active metabolites
B Schmidt et al.
JOURNAL OF MEDICINAL CHEMISTRY (2003)
Potential of renin inhibition in cardiovascular disease
A Stanton
JOURNAL OF THE RENIN-ANGIOTENSIN-ALDOSTERONE SYSTEM (2003)
Angiotensin AT1/AT2 receptors: Regulation, signalling and function
E Kaschina et al.
BLOOD PRESSURE (2003)
CoMFA and CoMSIA studies of angiotensin (AT1) receptor antagonists
P Datar et al.
JOURNAL OF MOLECULAR MODELING (2002)
Graph valence shells as molecular descriptors
M Randic
JOURNAL OF CHEMICAL INFORMATION AND COMPUTER SCIENCES (2001)
How can the differences among AT(1)-Receptor antagonists be explained?
P Morsing et al.
CELL BIOCHEMISTRY AND BIOPHYSICS (2001)
Angiotensin II type 1 receptor blockade: a novel therapeutic concept
CI Johnston
BLOOD PRESSURE (2000)
分享论文
